Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

RMC 035

Next Previous
Drug Profile

RMC 035

Alternative Names: A1M-001; Alfa-1-Mikroglobulin - Guard Therapeutics; Alpha-1-microglobulin - Guard Therapeutics; RMC-035; ROSgard; α1-microglobulin - Guard Therapeutics

Latest Information Update: 31 Dec 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator A1M Pharma AB
  • Developer Guard Therapeutics
  • Class Antihypertensives; Radioprotectives; Recombinant proteins; Urologics
  • Mechanism of Action Alpha 1 microglobulin replacements; Antioxidants; Free radical scavengers; Haemoglobin inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Preeclampsia
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Discontinued Acute kidney injury; Preeclampsia; Radiation injuries; Sepsis

Most Recent Events

  • 04 Dec 2025 Discontinued - Phase-I for Acute kidney injury in Sweden (IV)
  • 04 Dec 2025 Discontinued - Phase-II for Acute kidney injury (In adults, In the elderly) in Canada (IV)
  • 04 Dec 2025 Discontinued - Phase-II for Acute kidney injury (In the elderly, In adults) in Germany (IV)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top